CTXR vs L · rev $7.1M vs P/E 14, rev $18.45B
Citius Pharmaceuticals Inc (CTXR) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
CTXR currently screens at market cap $13.4M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the CTXR and L stock pages for the full models.
Not investment advice.